KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Change in Cash (2016 - 2025)

Cme (CME) has disclosed Change in Cash for 17 consecutive years, with $12.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Change in Cash rose 147958.82% to $12.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $62.3 billion, a 617.21% increase, with the full-year FY2025 number at $62.3 billion, up 617.21% from a year prior.
  • Change in Cash was $12.6 billion for Q4 2025 at Cme, up from $7.3 billion in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $36.0 billion in Q1 2021 to a low of -$29.5 billion in Q2 2022.
  • A 5-year average of $3.8 billion and a median of $5.5 billion in 2023 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: plummeted 1527.99% in 2023, then surged 147958.82% in 2025.
  • Cme's Change in Cash stood at $10.1 billion in 2021, then crashed by 140.82% to -$4.1 billion in 2022, then skyrocketed by 187.35% to $3.6 billion in 2023, then crashed by 99.76% to $8.5 million in 2024, then soared by 147958.82% to $12.6 billion in 2025.
  • Per Business Quant, the three most recent readings for CME's Change in Cash are $12.6 billion (Q4 2025), $7.3 billion (Q3 2025), and $22.0 billion (Q2 2025).